Business Context and Reporting Period
Company: Retractable Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 7, 2008 (covering events from October 24, 2007, through April 3, 2008)
Business Overview: The company manufactures safety syringes, including the VanishPoint product line. The filing addresses corporate governance amendments and significant litigation events.
Key Financial Metrics
Revenue: The filing references a press release dated April 3, 2008, reporting 2007 sales of $26.3 million.
Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for net income, operating cash flow, profit margins, debt levels, or liquidity ratios. These metrics are not detailed in this specific 8-K report.
Material Changes and Corporate Actions
- Corporate Governance: On October 24, 2007, the company amended its Articles of Incorporation to change the Registered Agent's address. On March 25, 2008, the Board adopted the Second Amended and Restated Bylaws to conform with the Texas Business Organizations Code (effective January 1, 2010). Changes included updates to voting lists, director vacancies, committee procedures, and electronic communication methods.
- Intellectual Property: The company received U.S. Patent No. 7,351,224 on April 1, 2008.
Outlook, Risks, and Contingencies
The filing highlights significant legal contingencies involving patent infringement and trade secret disputes:
- Defensive Litigation: On March 14, 2008, MedSafe Technologies LLC sued Retractable Technologies and Becton Dickinson (BD) in South Carolina, alleging infringement of U.S. Patent No. 6,074,370 regarding the VanishPoint and Integra product lines. Plaintiffs seek unspecified damages.
- Offensive Litigation vs. BD: On April 1, 2008, the company sued BD in Texas for infringing U.S. Patent No. 7,351,224. The company seeks actual damages, treble damages, attorneys' fees, and a permanent injunction.
- Offensive Litigation vs. OMI: On April 1, 2008, the company sued Occupational & Medical Innovations, Ltd. (OMI) in Texas for willful patent infringement (Patents 6,572,584 and 7,351,224), theft of confidential information, and false advertising. The company seeks damages, injunctions, and treble damages.
- Status: No trial dates have been set for any of the aforementioned cases.
Investor Verification Checklist
- Verify the full text of the April 3, 2008 press release to confirm the $26.3 million 2007 sales figure and any additional financial context.
- Review the Second Amended and Restated Bylaws (Exhibit 3(ii)) to understand specific changes to shareholder voting rights and director procedures.
- Monitor the status of the three active lawsuits (MedSafe v. RTI/BD; RTI v. BD; RTI v. OMI) for potential financial impact or injunctions.
- Confirm the validity and scope of U.S. Patent No. 7,351,224 issued on April 1, 2008.